Clinical trials

Completed

A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients.

REP0204

What is the purpose of this study?

The objective of this clinical trial was to explore the safety and efficacy of repertaxin in preventing the delayed graft function (DGF) after kidney transplantation.

Trial overview

Condition

Ischemia-Reperfusion Injury in Kidney Transplantation

Study Identifiers

NCT00248040

Study type

Interventional

Intervention

Drug: reparixin continuous infusion
Drug: Reparixin intermittent infusion
Other: placebo infusion

Phase

II

Start date

May 2005

End Date

May2008

Enrollment Goal

100 patients

Going deep into the trial

Eligibility/Recruitment

Age

 
18
 
65

Gender

Accepts healthy volunteers

Key Criteria

close

Inclusion

close

Exclusion

Desired Outcomes

close

Primary Outcomes

close

Secondary Outcomes

Find your nearest centre:

Loading...

loading...